PlumX Metrics
Embed PlumX Metrics

Recent advances in graphdiyne materials for biomedical applications

Nano Today, ISSN: 1748-0132, Vol: 46, Page: 101616
2022
  • 16
    Citations
  • 0
    Usage
  • 13
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    16
  • Captures
    13
  • Mentions
    1
    • News Mentions
      1
      • 1

Most Recent News

Researchers from Chinese Academy of Sciences Discuss Findings in Biotechnology (Recent Advances In Graphdiyne Materials for Biomedical Applications)

2022 NOV 30 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech News Daily -- Investigators publish new report on Biotechnology. According to news

Review Description

As the new member of carbon-based nanomaterials, graphdiyne features the coexistence of sp and sp 2 hybridized carbon atoms with a unique planar structure and highly conjugated structure. Since the firstly experimental synthesis of graphdiyne in 2010, the research on intrinsic structure and property, as well as wide applications in catalysis, energy, environment, and biomedicine related fields have attracted tremendous attention. In this review article, the fundamental electrical and optical properties of GDY are briefly introduced, and a comprehensive update on the biomedical applications of GDY and its derivatives by virtue of the distinct functionality and tailored property are provided. GDY and its derivatives have been verified as superior materials for biomedical applications, and it is believed that these applications provide feasibility for their future clinical applications through in-depth studies on GDY with diverse structures and properties.

Bibliographic Details

Wen Yu; Gang Song; Fengting Lv; Yiming Huang; Haotian Bai; Shu Wang

Elsevier BV

Biochemistry, Genetics and Molecular Biology; Chemical Engineering; Engineering; Materials Science; Pharmacology, Toxicology and Pharmaceutics

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know